First Time Loading...
C

Clarus Therapeutics Holdings Inc
NASDAQ:CRXT

Watchlist Manager
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Watchlist
Price: 0.021 USD -19.54% Market Closed
Updated: Jun 11, 2024

Clarus Therapeutics Holdings Inc
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Clarus Therapeutics Holdings Inc
Additional Paid In Capital Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
C
Clarus Therapeutics Holdings Inc
NASDAQ:CRXT
Additional Paid In Capital
$305.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Additional Paid In Capital
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bristol-Myers Squibb Co
NYSE:BMY
Additional Paid In Capital
$45.7B
CAGR 3-Years
1%
CAGR 5-Years
85%
CAGR 10-Years
41%
Pfizer Inc
NYSE:PFE
Additional Paid In Capital
$93B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
2%
Merck & Co Inc
NYSE:MRK
Additional Paid In Capital
$44.6B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Additional Paid In Capital
$7B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
3%

See Also

What is Clarus Therapeutics Holdings Inc's Additional Paid In Capital?
Additional Paid In Capital
305.7m USD

Based on the financial report for Dec 31, 2021, Clarus Therapeutics Holdings Inc's Additional Paid In Capital amounts to 305.7m USD.